Public Company News
Dizal Reveals New Findings from Biomarker Analysis, Highlighting Sunvozertinib as an Effective Treatment for Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
* Anittumor efficacy of sunvozertinib was observed in patients regardless of baseline EGFR exon20ins status in plasma ctDNA. * Sunvozertinib could effectively clear EGFR exon20ins in plasma ctDNA, confirming its direct effect on EGFR pathway. * The resistance to sunvozertinib could be thro...
2024-05-24 16:32
2678
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates
SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its four abstracts selected for presentations a...
2024-05-24 09:15
2782
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024
Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression, including in patients with PD-L1 CPS<5. PRINCETON, N.J. and SUZHOU, China, May 23, 2024 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a global clinical stage biopharm...
2024-05-24 08:00
2851
Infobird Co., Ltd Receives Notification from Nasdaq for Failure to Timely File Form 20-F
HONG KONG, May 23, 2024 /PRNewswire/ -- Infobird Co., Ltd (NASDAQ: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of AI-powered customer engagement solutions inChina, today reports that as of May 16, 2024, it is delinquent in filing its annual report on Form 20-F for the fi...
2024-05-24 06:00
4325
SEMIFIVE Signs MOU with Atron Technologies to Collaborate on Semiconductor Design
Expected to expand global business in the Chinese market SEOUL, South Korea, May 23, 2024 /PRNewswire/ -- SEMIFIVE, a leading design solution provider and pioneer of platform-based custom silicon solutions, has announced its agreement of MOU withChina-based Atron Technologies, on May 23, 2024. T...
2024-05-24 06:00
4231
Emeren Announces First Quarter 2024 Financial Results
STAMFORD, Conn., May 23, 2024 /PRNewswire/ -- Emeren Group Ltd ("Emeren" or the
"Company") (www.emeren.com
2024-05-24 04:05
4185
Computex 2024: DeCloak Intelligences Showcases DeCloakVision Multi-Modal AI Privacy-Enhanced Monitoring System Offering the Optimal Balance between Public Safety & Personal Privacy
LAS VEGAS and TAIPEI, May 23, 2024 /PRNewswire/ -- DeCloak Intelligences, a subsidiary of Etron Technology (TPEx: 5351), has won the CES Innovation Award for two consecutive years and its privacy system has also been recognized with the Excellent Manufacturer Innovation Product Award inTaiwan. De...
2024-05-23 22:00
3801
Recon Technology Regains Nasdaq Compliance; Hearing Moot
BEIJING, May 23, 2024 /PRNewswire/ -- Recon Technology, Ltd. (NASDAQ: RCON) ("Recon" or the "Company") announced today that onMay 22, 2024, it had received a letter datedMay 22, 2024 (the "Compliance Letter") from the Listing Qualifications Hearings Department of Nasdaq notifying the Company that...
2024-05-23 21:59
5234
MINISO Announces Change of Venue for Annual General Meeting on June 20, 2024
GUANGZHOU, China, May 23, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced that due to administrative reasons, the ve...
2024-05-23 21:10
2920
Laekna Announces FDA Approval for the Phase III Clinical Trial Protocol of LAE002 (Afuresertib) PLUS LAE001 for the Treatment of Prostate Cancer
SHANGHAI and WARREN, N.J., May 23, 2024 /PRNewswire/ -- Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food and Drugs Administration for the protocol of the phase III clinical trial of LAE002 (afureser...
2024-05-23 20:42
2581
Rapid Development of AI with A Vast Market: Visionary Holdings Inc. Provides STEM-AI Education Solutions for Young People
TORONTO, May 23, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries inCanada and market partners inChina, today announced the Company is a leadin...
2024-05-23 20:30
4531
Snail Inc's ARK: Survival Ascended Leads the Market with Premium Mods for Console, Opening New Revenue Streams
The launch of premium mods on console expands monetization opportunities for modders and indicates an exponential growth opportunity for the ARK Universe CULVER CITY, Calif., May 23, 2024 /PRNewswire/ -- Snail, Inc. (Nasdaq: SNAL) ("Snail" or "the Company"), a leading, global independent develope...
2024-05-23 20:00
2271
Recurrent Energy Secures Landmark Green, Multi-currency Financing for up to €1.3 Billion to Accelerate European Renewable Energy Portfolio
The revolving credit facility will provide flexible financing for the
construction of solar and battery energy storage projects acrossSpain, Italy,
theUnited Kingdom, the Netherlands, France, and Germany
GUELPH, ON, May 23, 2024 /PRNewswire/ -- Recurrent Energy
2024-05-23 19:00
4670
X Financial to Report First Quarter 2024 Financial Results on May 29, 2024
SHENZHEN, China, May 23, 2024 /PRNewswire/ -- X Financial (NYSE: XYF) (the "Company"), a leading online personal finance company inChina, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2024, before the open of U.S. markets on Wednesday, M...
2024-05-23 18:00
3914
Weibo Announces First Quarter 2024 Unaudited Financial Results
BEIJING, May 23, 2024 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (NASDAQ: WB and HKEX: 9898), a leading social media inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2024. "We had a solid start to the year," said Gaofei Wang, CEO of ...
2024-05-23 17:00
4224
111, Inc. Announces First Quarter 2024 Unaudited Financial Results
* Turned to Quarterly Operational Profitability for the First Time * Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY to 5.8% * Achieved Positive Operating Cash Flow SHANGHAI, May 23, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading...
2024-05-23 16:43
4349
NetEase Announces First Quarter 2024 Unaudited Financial Results
HANGZHOU, China, May 23, 2024 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced its unaudited financial results for the first quarter endedMarch 31, 2024. First Quarter 2024 Financial Highlights...
2024-05-23 16:30
4453
Youdao Reports First Quarter 2024 Unaudited Financial Results
HANGZHOU, China, May 23, 2024 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE: DAO), an intelligent learning company with industry-leading technology inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2024. First Quarter 2024 Financial Hi...
2024-05-23 16:30
4036
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, Presented Preclinical Data on Eye Drops from its Proprietary OPC Platform at ARVO 2024
* Presentation at ARVO 2024 gained attention as Eylea (aflibercept) eye drops demonstrated similar efficacy to intravitreal injections in animal studies. DAEJEON, South Korea , May 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ:208340), a clinical-stage publ...
2024-05-23 08:51
2673
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
CAMBRIDGE, Mass., May 22, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a license agreemen...
2024-05-23 07:23
2258
Week's Top Stories
Most Reposted
Singapore imagines new ways of living at Milan Design Week with the opening of Prototype Island
[Picked up by 304 media titles]
2026-04-21 10:28
THAIFEX - Anuga Asia 2026 Returns As the Industry's Business Catalyst -- at a Time the F&B Sector Needs It Most
[Picked up by 294 media titles]
2026-04-23 11:00Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
[Picked up by 293 media titles]
2026-04-21 18:00
DayOne Launches Inaugural Tech & AI Career Expo in Thailand, Showcasing Commitment to Digital Infrastructure and Talent Development
[Picked up by 287 media titles]
2026-04-25 23:06
Hong Leong Bank Sets the Stage for Malaysia's Largest Music Festival; Partners with JOOX and QQ Music for AsiaTop Music Festival 2026
[Picked up by 287 media titles]
2026-04-23 19:23
Most Read
Blaize and Datacomm Sign Technology Alliance MOU to Explore AI Inference Solutions Across Indonesia
2026-04-21 18:00
5604
/C O R R E C T I O N -- TCL/
2026-04-22 12:01
5054
RoboSense Unveiled EOCENE SPAD-SoC Architecture and Chipsets Phoenix and Peacock: Ushering the LiDAR Industry into the Image-grade Era of High-Definition 3D Perception
2026-04-21 15:55
4844
/C O R R E C T I O N -- Empyrion Digital/
2026-04-21 12:25
4757
Cognizant and OpenAI Partner to Reshape Enterprise Software Engineering with Codex
2026-04-21 21:15
4728